US L-Citrulline Market Research Report Information By Type (Power Type and Crystal Type), By Classification (Medical Grade and Food Grade), By Application (Cosmetic & Personal Care, Food & Beverages, Pharmaceuticals, Agriculture, Animal Feed and Other), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

The burgeoning food and beverage industry, marked by increased investments in nutritional and performance drinks due to evolving dietary preferences, is a significant driver of the L-citrulline market in North America. The region's established healthcare sector, coupled with the growing prevalence of obesity, heart diseases, and kidney disorders resulting from the escalated consumption of sugar-sweetened beverages and unhealthy diets, has led to a surge in the demand for drugs containing L-citrulline in the United States. Furthermore, the approval of pharmaceutical-grade L-citrulline by the US Food and Drug Administration (FDA) as an Active Pharmaceutical Ingredient (API), suitable for various formulations like powder, tablets, capsules, or liquid, adds to the market's impetus.
In 2017, the US dominated the L-citrulline market, capturing the largest market share of 81.48%, equivalent to a market value of USD 4,966.3 Thousand. The forecast predicts a Compound Annual Growth Rate (CAGR) of 5.30% for the US market during the projection period. Canada, the second-largest market in 2017, held a value of USD 1,128.6 Thousand, and it is anticipated to grow at the highest CAGR of 5.42%.

Market segmentation based on volume reveals a similar dominance of the US, with a market share of 81.18% and a volume of 143.56 Tons in 2017. The US market is expected to grow at a CAGR of 4.84%. Canada, the second-largest segment with a market share of 18.82% in 2017 and a volume of 33.27 Tons, is projected to grow at the highest CAGR of 5.21%.

Analyzing the market by application, the food and beverage sector secured the largest market share of 37.06% in 2017, amounting to a market value of USD 2,259.0 Thousand. The forecast suggests a CAGR of 4.95% for this segment. Pharmaceuticals emerged as the second-largest market in 2017, valued at USD 1,939.9 Thousand, and it is expected to grow at the highest CAGR of 5.89%.

Examining the market by volume for the food and beverage sector, it maintained its dominance with a market share of 37.18%, representing a volume of 65.74 Tons in 2017. The forecast anticipates a CAGR of 4.33% for this segment. Pharmaceuticals, the second-largest segment with a market share of 31.55% in 2017 and a volume of 55.8 Tons, is projected to grow at the highest CAGR of 5.59%.

A similar trend is observed when analyzing the market by value and volume for the pharmaceutical sector. In terms of market value, food and beverage claimed the largest share of 37.43%, valued at USD 1,858.9 Thousand in 2017, with a projected CAGR of 4.96%. Pharmaceuticals, the second-largest segment with a market value of USD 1,564.0 Thousand in 2017, is anticipated to grow at the highest CAGR of 5.83%.

Regarding volume, the food and beverage segment dominated with a market share of 37.52%, accounting for a volume of 53.86 Tons in 2017. The forecast predicts a CAGR of 4.29% for this segment. Pharmaceuticals, the second-largest segment with a market share of 31.24% in 2017 and a volume of 44.8 Tons, is projected to grow at the highest CAGR of 5.51%.